Switch to:
More From Other Websites
CytRx to Present at the Cowen & Company 35th Annual Health Care Conference Feb 25 2015
CytRx to Present at the Cowen & Company 35th Annual Health Care Conference Feb 25 2015
CytRx Announces Overall Survival Results from Its Global Phase 2b Clinical Trial of Aldoxorubicin in... Feb 11 2015
CytRx Announces FDA's Removal of Partial Clinical Hold for Aldoxorubicin Clinical Trials Permitting... Feb 11 2015
CytRx to Present at the 17th Annual BIO CEO & Investor Conference on February 9, 2015 in New York... Feb 02 2015
CytRx Candidate Encourages in Soft Tissue Sarcoma Study - Analyst Blog Jan 26 2015
Mettler-Toledo International Inc Earnings Call scheduled for 11:00 am ET today Jan 22 2015
CytRx Announces Overall Survival Results from Its Global Phase 2b Clinical Trial of Aldoxorubicin in... Jan 22 2015
CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog Jan 21 2015
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted -... Jan 21 2015
Ahead of the Bell: CytRx climbs as FDA lifts research hold Jan 20 2015
Ahead of the Bell: CytRx climbs as FDA lifts research hold Jan 20 2015
CytRx Announces FDA's Removal of Partial Clinical Hold for Aldoxorubicin Clinical Trials Permitting... Jan 20 2015
CytRx cancer drug shows promise in mid-stage study Jan 08 2015
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related... Jan 08 2015
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related... Jan 08 2015
Aegis Capital Reiterates Buy On CytRx As Stock Soars 17% Jan 06 2015
Midday movers: Chevron, Hess, Morgan Stanley & more Jan 06 2015
BUZZ-U.S. STOCKS ON THE MOVE-Frontline, Michael Kors, Minerva Jan 06 2015
CytRx Reports Positive Results for Brain Cancer Treatment Jan 06 2015
Cytrx cancer drug shows promise in mid-stage study Jan 06 2015
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain... Jan 06 2015
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain... Jan 06 2015
Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ... Dec 15 2014
CytRx Falls on Written FDA Notice for Aldoxorubicin Study Dec 04 2014
CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical... Dec 03 2014
CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical... Dec 03 2014
CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference Dec 02 2014
CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference Dec 02 2014
CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials Nov 18 2014
Amarantus passe un accord d’option exclusive pour l’acquisition auprès de Lonza d’un... Nov 17 2014
CytRx Reports 2014 Third Quarter Financial Results Nov 04 2014
CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium Oct 30 2014
CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data in Soft Tissue Sarcoma in... Oct 20 2014
CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue... Oct 17 2014
CytRx Appoints Steven A. Kriegsman as Chairman of the Board Oct 16 2014
CytRx Issues Statement Regarding Recent Lawsuits Mar 27 2014
CytRx Initiates Pivotal Global Phase 3 Clinical Trial with Aldoxorubicin for Second-Line Treatment... Mar 24 2014
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION... Mar 17 2014
CytRx Establishes Research and Development Team and Opens New Laboratory to Develop Albumin-Binding... Mar 17 2014
CytRx Reports 2013 Financial Results Mar 05 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK